Welcome to the InfoSci Platform
Use of a Blockchain-Based Marketplace to Incentivize Participation in Virtual Clinical Trials

Use of a Blockchain-Based Marketplace to Incentivize Participation in Virtual Clinical Trials

Phillip Olla, Mustafa Taher Abumeeiz, Lauren Kay Elliott, Vijay Rajasekar, Stephen Bartol
Copyright: © 2021 |Volume: 1 |Issue: 1 |Pages: 14
EISSN: 2767-3804|EISBN13: 9781799883708|DOI: 10.4018/JTA.20210101.oa4
Cite Article Cite Article

MLA

Olla, Phillip, et al. "Use of a Blockchain-Based Marketplace to Incentivize Participation in Virtual Clinical Trials." JTA vol.1, no.1 2021: pp.1-14. http://doi.org/10.4018/JTA.20210101.oa4

APA

Olla, P., Abumeeiz, M. T., Elliott, L. K., Rajasekar, V., & Bartol, S. (2021). Use of a Blockchain-Based Marketplace to Incentivize Participation in Virtual Clinical Trials. Journal of Technological Advancements (JTA), 1(1), 1-14. http://doi.org/10.4018/JTA.20210101.oa4

Chicago

Olla, Phillip, et al. "Use of a Blockchain-Based Marketplace to Incentivize Participation in Virtual Clinical Trials," Journal of Technological Advancements (JTA) 1, no.1: 1-14. http://doi.org/10.4018/JTA.20210101.oa4

Export Reference

Mendeley
Favorite Full-Issue Download

Abstract

There is an emerging need for advancements in how clinical trials are conducted in the current pandemic situation. Healthcare institutions are moving towards using digital technologies to avoid physical interactions between doctors and clinical trial participants. However, difficulties in recruiting and retaining participants are still prevalent. To overcome this issue, an incentive system that can be trusted by doctors as well as trial participants is required. The authors present a detailed report of Cashish, a blockchain-based incentivization system that rewards trial participants in the form of cryptocurrency tokens that they can utilize in an online marketplace that is also backed by the same blockchain. Usage of blockchain technology to provide research participation incentives eliminates the need for trust systems and ensures transparency between doctors and clinical trial participants, while ensuring participant anonymity.